+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Thermo Fisher Scientific Inc Stock Falls Wednesday, Still Outperforms Market is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Thermo Fisher Scientific Inc Stock Falls Wednesday, Still Outperforms Market | RobinsPost News & Noticias

Thermo Fisher Scientific Inc. stock falls Wednesday, underperforms market


Thermo Fisher Scientific Inc. closed 24.23% short of its 52-week high of $623.77, which the company achieved on September 27th. Read More

Why Thermo Fisher Scientific Stock Tumbled Today


Thermo Fisher Scientific › Sprawling medical device and solutions company Thermo Fisher Scientific (NYSE: TMO) wasn't looking all that healthy on Tuesday, at least as far as its stock was concerned. Read More

Beyond The Numbers: 11 Analysts Discuss Thermo Fisher Scientific Stock


Insights from analysts' 12-month price targets are revealed, presenting an average target of $521.82, a high estimate of $590.00, and a low estimate of $450.00. Surpassing the previous average price ... Read More

Thermo Fisher Scientific Inc.


About Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc. serves the scientific community through a broad offering of innovative products and services. Thermo Fisher Scientific serves ... Read More

Strategic Sale: Joseph R Holmes Decides To Exercise Options Worth $88K At Thermo Fisher Scientific


Currently, Thermo Fisher Scientific shares are trading down 0.77%, priced at $483.79 during Wednesday's morning. This values Holmes's 385 shares at $88,473. Read More

Barclays Upgrades Thermo Fisher Scientific to Overweight


Barclays analyst Luke Sergott cited stable end market demand as well as the company's strong Q2 2025 financial results and full-year 2025 guidance raise. Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus